UnknownNCT04688996
Yersinia Pestis Lateral Flow Immunoassay for Blood Samples
Studying Plague
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Brimrose Technology Corporation
- Principal Investigator
- Dawn J Birdsell, Ph.D.Northern Arizona University
- Intervention
- Lateral Flow Assay for Pathogens of the Plague(diagnostic_test)
- Enrollment
- 500 target
- Eligibility
- 5-75 years · All sexes
- Timeline
- 2020 – 2023
Study locations (2)
- US Naval Health Research Center, San Diego, California, United States
- Institut Pasteur de Madagascar, Antananarivo, Analamanga Region, Madagascar
Collaborators
Northern Arizona University · New Horizons Diagnostics Corporation · Institut Pasteur de Madagascar · Naval Health Research Center
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04688996 on ClinicalTrials.govOther trials for Plague
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07207408Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of AgeDynavax Technologies Corporation
- RECRUITINGPHASE1NCT06943378Ph1, Randomized, Double-Blind and Controlled, Dose Escalation and Expansion Study to Assess the Safety and Pharmacokinetics of JST-010 in Healthy AdultsJust-Evotec Biologics
- RECRUITINGNANCT06083649The Dental Care Revolution: Health Education Using AI or Humanized Counseling on Plague Control and Periodontal Treatment Outcome in Patients With Periodontal DiseaseKaohsiung Medical University Chung-Ho Memorial Hospital